Wireless’ deep brain stimulation technique offers promising potential for neurodegenerative diseases BEIJING — Parkinson’s ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately 20 ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

Researchers developed a wireless photothermal nanosystem using gold nanoshells to stimulate thermosensitive TRPV1 receptors ...

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms of Parkinson's disease in Amsterdam this week, Amsterdam UMC reported. The ...

For the people it affects (and anyone who shares a bed with them) restless legs syndrome (RLS) is a torturous condition.

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...